# Improving Retreatment Success (IMPRESS)

> **NCT02114684** · PHASE1,PHASE2 · COMPLETED · sponsor: **Centre for the AIDS Programme of Research in South Africa** · enrollment: 197 (actual)

## Conditions studied

- Recurrent Tuberculosis

## Interventions

- **DRUG:** moxifloxacin

## Key facts

- **NCT ID:** NCT02114684
- **Lead sponsor:** Centre for the AIDS Programme of Research in South Africa
- **Sponsor class:** NETWORK
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2017-07
- **Final completion:** 2017-07-17
- **Target enrollment:** 197 (ACTUAL)
- **Last updated:** 2019-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02114684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02114684, "Improving Retreatment Success (IMPRESS)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02114684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*